000 02410 a2200709 4500
005 20250516122942.0
264 0 _c20130308
008 201303s 0 0 eng d
022 _a1944-7884
024 7 _a10.1097/QAI.0b013e31827b51b5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMills, Anthony
245 0 0 _aMaraviroc once-daily nucleoside analog-sparing regimen in treatment-naive patients: randomized, open-label pilot study.
_h[electronic resource]
260 _bJournal of acquired immune deficiency syndromes (1999)
_cFeb 2013
300 _a164-70 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdenine
_xanalogs & derivatives
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnti-HIV Agents
_xtherapeutic use
650 0 4 _aAtazanavir Sulfate
650 0 4 _aCCR5 Receptor Antagonists
650 0 4 _aCD4 Lymphocyte Count
650 0 4 _aCyclohexanes
_xadverse effects
650 0 4 _aDeoxycytidine
_xanalogs & derivatives
650 0 4 _aDrug Therapy, Combination
_xadverse effects
650 0 4 _aEmtricitabine
650 0 4 _aFemale
650 0 4 _aHIV Fusion Inhibitors
_xadverse effects
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHIV-1
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMaraviroc
650 0 4 _aMiddle Aged
650 0 4 _aOligopeptides
_xtherapeutic use
650 0 4 _aOrganophosphonates
_xtherapeutic use
650 0 4 _aPilot Projects
650 0 4 _aPyridines
_xtherapeutic use
650 0 4 _aRNA, Viral
_xblood
650 0 4 _aRitonavir
_xtherapeutic use
650 0 4 _aTenofovir
650 0 4 _aTriazoles
_xadverse effects
650 0 4 _aViral Load
650 0 4 _aYoung Adult
700 1 _aMildvan, Donna
700 1 _aPodzamczer, Daniel
700 1 _aFätkenheuer, Gerd
700 1 _aLeal, Manuel
700 1 _aThan, Soe
700 1 _aValluri, Srinivas R
700 1 _aCraig, Charles
700 1 _aMcFadyen, Lynn
700 1 _aVourvahis, Manoli
700 1 _aHeera, Jayvant
700 1 _aValdez, Hernan
700 1 _aRinehart, Alex R
700 1 _aPortsmouth, Simon
773 0 _tJournal of acquired immune deficiency syndromes (1999)
_gvol. 62
_gno. 2
_gp. 164-70
856 4 0 _uhttps://doi.org/10.1097/QAI.0b013e31827b51b5
_zAvailable from publisher's website
999 _c22297757
_d22297757